Trial Profile
Lutropin Alfa (Luveris) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age: Phase II Clinical Trial.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 12 Apr 2022
Price :
$35
*
At a glance
- Drugs Lutropin alfa (Primary) ; Follitropin alfa
- Indications Female infertility
- Focus Adverse reactions; Therapeutic Use
- Sponsors Merck KGaA
- 09 Apr 2022 This trial has been completed in Spain (Global end date: 31-10-2010), according to European Clinical Trials Database record.
- 23 Mar 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 08 Mar 2010 New trial record